TP53 and cancer: Figure 1 shows an illustrative scheme of the MDM2-p53 relationship. In many cancers, MDM2 is overexpressed, suppressing p53 activity and allowing uncontrolled cell proliferation [3,4,5,6,7]. Due to its pivotal role, MDM2 has been recognized as an attractive target for cancer therapy [8].